Attached files

file filename
EX-31.2 - CERTIFICATION - Cellular Biomedicine Group, Inc.cmbg_ex312.htm
EX-31.1 - CERTIFICATION - Cellular Biomedicine Group, Inc.cmbg_ex311.htm
EX-10.11 - AMENDED AND RESTATED 2011 INCENTIVE STOCK OPTION PLAN - Cellular Biomedicine Group, Inc.cmbg_ex1011.htm
EXCEL - IDEA: XBRL DOCUMENT - Cellular Biomedicine Group, Inc.Financial_Report.xls
10-Q - QUARTERLY REPORT - Cellular Biomedicine Group, Inc.cmbg_10q.htm
EX-99.1 - SUPPLEMENTAL PRO-FORMA INCOME STATEMENT - Cellular Biomedicine Group, Inc.cmbg_ex991.htm


In connection with the periodic report of Cellular Biomedicine Group, Inc. (the “Company”) on Form 10-Q for the quarter ending March 31, 2013 as filed with the Securities and Exchange Commission (the “Report”), we, Wen Tao (Steve) Liu, Chief Executive Officer (Principal Executive Officer) and Andrew Chan, Chief Financial Officer (Principal Financial and Accounting Officer) of the Company, hereby certify as of the date hereof, solely for purposes of Title 18, Chapter 63, Section 1350 of the United States Code, that to the best of our knowledge:

(1)           The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and

(2)           The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated.
Date: May 20, 2013
  /s/ Wen Tao (Steve) Liu  
    Wen Tao (Steve) Liu  
    Chief Executive Officer  
    (Principal Executive Officer)  
    /s/ Andrew Chan  
    Andrew Chan  
    Chief Financial Officer  
    (Principal Financial and Accounting Officer)